These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 973975)
1. Studies on the metabolism of meptazinol, a new analgesic drug. Franklin RA; Aldridge A Br J Clin Pharmacol; 1976 Jun; 3(3):497-502. PubMed ID: 973975 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of the new analgesic meptazinol in rats and patas monkeys. Franklin RA; Aldridge A Xenobiotica; 1976 Aug; 6(8):499-508. PubMed ID: 824868 [TBL] [Abstract][Full Text] [Related]
3. Studies on the absorption and disposition of meptazinol following rectal administration. Franklin RA; Southgate PJ; Coleman AJ Br J Clin Pharmacol; 1977 Apr; 4(2):163-7. PubMed ID: 405029 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the new analgesic, meptazinol, after oral and intravenous administration to volunteers. Norbury HM; Franklin RA; Graham DF Eur J Clin Pharmacol; 1983; 25(1):77-80. PubMed ID: 6617729 [TBL] [Abstract][Full Text] [Related]
5. Quantitative aspects of the urinary excretion of meptazinol and its metabolites in human volunteers. Murray GR; Whiffin GM; Franklin RA; Henry JA Xenobiotica; 1989 Jun; 19(6):669-75. PubMed ID: 2669363 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Nave R; Bethke TD; van Marle SP; Zech K Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of labetalol by animals and man. Martin LE; Hopkins R; Bland R Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
10. Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man. Dieterle W; Faigle JW; Mory H; Richter WJ; Theobald W Eur J Clin Pharmacol; 1975 Dec; 9(2-3):135-45. PubMed ID: 786687 [TBL] [Abstract][Full Text] [Related]
11. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose. Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of premazepam, a new potential anxiolytic, in humans. Vitiello B; Buniva G; Bernareggi A; Assandri A; Perazzi A; Fuccella LM; Palumbo R Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):273-7. PubMed ID: 6146571 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
14. Blood level, excretion, and metabolite pattern of [14C]-brotizolam in humans. Bechtel WD; van Wayjen RG; van den Ende A Arzneimittelforschung; 1986 Mar; 36(3A):575-8. PubMed ID: 3718580 [TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
16. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
17. The metabolic disposition of 14C-ciramadol in humans. Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997 [TBL] [Abstract][Full Text] [Related]
18. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
19. Absorption, metabolism and excretion of darexaban (YM150), a new direct factor Xa inhibitor in humans. Hashimoto T; Suzuki K; Kihara Y; Iwatsubo T; Miyashita A; Heeringa M; Onkels H; Groenendaal D; Verheggen F; van Marle S; Usui T Xenobiotica; 2013 Jun; 43(6):534-47. PubMed ID: 23167531 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans]. Hlavica P; Niebch G Arzneimittelforschung; 1985; 35(1):67-74. PubMed ID: 4039154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]